Results 151 to 160 of about 7,965 (181)
Some of the next articles are maybe not open access.
Detecting and treating primary aldosteronism: primary aldosteronism.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2007Primary aldosteronism (PA) is the most common cause of mineralocorticoid hypertension. Different studies, using the plasma aldosterone concentration to plasma renin activity ratio (PAC/PRA) for the screening of patients with hypertension, have shown a marked increase in the detection rate of PA.
MANTERO, FRANCO +2 more
openaire +2 more sources
Primary aldosteronism and aldosterone-associated hypertension
Journal of Clinical Pathology, 2008The field of primary aldosteronism (PA) and aldosterone-related hypertension has undergone rapid evolution. From a relatively rare curiosity PA has become a common problem particularly in selected hypertensive populations. Patients with PA and aldosterone-related hypertension appear to be at higher cardiovascular and renal risk than comparable patients
openaire +2 more sources
Treatment of Primary Aldosteronism
HypertensionPrimary aldosteronism (PA) is a common cause of hypertension, characterized by renin-independent aldosterone production that drives inappropriate mineralocorticoid receptor activation, sodium retention, volume expansion, and potassium wasting, ultimately resulting in hypertension and adverse cardiorenal ...
Stéfanie Parisien-La Salle +4 more
openaire +2 more sources
Screening for primary aldosteronism in pregnancy
Pregnancy Hypertension, 2021Adam Morton, Sailesh Kumar
exaly
Performance of the Aldosterone to Renin Ratio as a Screening Test for Primary Aldosteronism
Journal of Clinical Endocrinology and Metabolism, 2021Marcel Ruzicka +2 more
exaly